Roy Exum: My Pimples And Andrea Sloan

Monday, September 30, 2013 - by Roy Exum
Roy Exum
Roy Exum

A real long time ago I was having a fit with acne. I was a lovelorn teenager, infatuated with pretty girls in a dizzy game where pimples can really become cumbersome. It seemed like nothing was working and, after I grew a pimple large enough for its own zip code, I finally found a genius doctor who quickly became my lifelong hero when he came up with a marvelous idea.

At the time there was a new “super drug”  that was languishing through years of “clinical trials” in the United States and nobody could get any, despite the fact the revolutionary medicine was already available in Germany. My hero called up a close friend who was a German doctor and – presto! – the first 250 pills came flying across the ocean.

I had to promise that I would not sue anybody if I grew an extra set of ears, developed female breasts, or my eyes turned yellow, but, honestly, I would have dyed my hair green to get the American-made medicine. After I took a course of what was then identified by only a strange laboratory number, my pimples and my acne were gone forever. I had Clark Gable looks and never looked back. That’s a true story (except the Gable part.)

Other fellow Americans had to wait for many months. I don’t believe that's right. Since this occurred in my formative years, I have cursed the federal Food and Drug Administration for much of my adult life because the “clinical trials” process we use is horribly dysfunctional and in critical need of an overhaul.

To illustrate my point, allow me to introduce a beautiful Texas lawyer, Andrea Sloan. Yes, she is quite pretty but “beautiful” because her career has been as the executive director of a Texas advocacy project that provides free legal services to low-income victims of domestic or sexual abuse.

Andrea is a victim herself, not just of stage 3c ovarian cancer but a horribly-tangled FDA system. Her doctors have exhausted every known method to save her life. Six years of surgery, radiation, and chemotherapy haven’t worked. She’s still very much a patient at the world-famous M.D. Anderson Medical Center and her oncologist believes an experimental drug called “BMN 673” might well save Andrea’s life.

M.D. Anderson has a good supply of BMN 673 on hand but with millions of dollars at stake, the manufacturer, BioMarin in California, has said no. “It would be unethical and reckless to provide end-stage refractory ovarian cancer patients outside clinical trial with BMN 673 at this early stage of development,” said spokesperson Debra Charlesworth.

“If we did,” Charlesworth explained to CNN, “we would be exposing the experimental drug to a large group without adequate testing. There have been previous circumstances where early access to large groups has resulted in adverse consequences that were worse than the course of the disease.”

I am certain no scientist can hardly wait for somebody to try to explain to me what “adverse consequences” could possibly be worse than what Andrea Sloan is facing without BMN 673. Andrea is pleading for the drug – let the petals of the flower fall where they may – and probably understands the risks as much as anyone involved. She knows what will happen if she fails to get BMN 673 better than anyone else, too.

Here is what she wrote in a statement to the drug company: “I recognize the importance of weighing the risk and the myriad of considerations they face as a company. However, this is a risk worth taking. I will thank them. My family will thank them. An amazing army of loyal supporters, to whom I owe a debt of gratitude, will thank them. In America we do not leave our wounded warriors on the battleground. BioMarin, please be the Calvary that saves me.”

Her M.D. Anderson doctors believe Andrea is a great candidate. Further, the FDA itself has just announced Ms. Sloan qualifies for a “compassionate care” waiver in the rules but the manufacturer, BioMarin, still says no. The word is BioMarin stands to make about $500 million on the drug and, even though they say they plan to give away 10 percent of the medicine to charity, they refuse to face the ethical dilemma.

As of Sunday afternoon Andrea had almost 170,000 supporters on her Change.org webpage and politician Newt Gingrich, co-host of CNN’s “Crossfire” program, is irate at “a corporation protecting its wallet at the expense on Andrea’s possibly dying. If you want to know why big companies often get bad names, it’s explaining that clerical support to fill out FDA paperwork is too difficult when you can save a life.”

Dr. Charles Levenback, Andrea’s doctor, is disappointed at BioMarin’s stance but, as a man who sees the fight against cancer every day, he told CNN reporters, “My own belief is that the drug companies, the manufacturers, the insurance companies, the providers like my hospital M.D. Anderson, the individual medical professionals, the investigators, the patients -- everybody wants the same things. Safe, effect, novel therapies for as many people as it's appropriate for. Even BioMarin, I believe. I don't think this is like 'Let the masses eat cake.' I think they're on the same mission. But the whole system is giving this dysfunctional result."

On Andrea Sloan’s Facebook page there is a picture that tells of “Three Simple Rules.” The text reads, “If you don’t go after what you want in life, you will never have it. If you don’t ask, the answer will always be No. If you don’t step forward, you’ll always be in the same place.”

Those three rules got rid of my pimples but all we can do is pray for Andrea Sloan. She needs it right now.

royexum@aol.com


Senator David Perdue: I Have Heard Every Excuse Under The Sun

Here we go again. For the 19th consecutive year, Washington has not funded the federal government on time. As the current continuing resolution is expiring in the midnight hour, Congress is once again trying to pass a temporary fix three months after the beginning of the current fiscal year. This is ridiculous. In fact, Congress has only completed the full budget process four ... (click for more)

Silence From Rhonda Thurman

I find it deplorable that Rhonda Thurman is, once again, voicing her opinions so quickly and so vehemently.  She seems to be the one school board member that wants media and/or press coverage every time the opportunity avails itself.  However, when it comes to responding to personal emails sent directly to her…she zips her lips. I, as all of the citizens of Hamilton ... (click for more)

Tennessee Members Of Congress Urge President To Approve Federal Disaster Assistance For Tennessee Counties

Members of Tennessee’s Congressional delegation on Saturday urged President Obama to quickly approve Governor Haslam’s request for a major disaster declaration for the State of Tennessee to help five Tennessee counties impacted by wildfires and severe weather in November rebuild and recover. “Governor Bill Haslam has submitted a request for Public Assistance and Individual ... (click for more)

1 Person Injured In Drive-by Shooting On North Germantown Road Friday Afternoon

A person was shot early Friday afternoon on North Germantown Road.  The Chattanooga Police Department responded at 1:45 p.m. to the 700 block of North Germantown Road on a person shot.   The victim was suffering from a non-life threatening gunshot wound, and  was transported to a local hospital by HCEMS.   The victim was shot from a suspect ... (click for more)

CSAS Gets Defensive In Win Over Boyd-Buchanan

High school basketball is still in the early stages of the 2016-17 season, but CSAS coach Mark Dragoo is already seeing improvement from his team and they’ve only played four games. The Patriots are always a good team with lots of quick, athletic players who can shoot well and play sticky defense. That was the case on Friday night at Boyd-Buchanan as the Patriots shot well ... (click for more)

Bradley Girls Stave Off Stone Memorial's Upset Bid, 48-46

The Bradley Central Bearettes’ ninth straight win to open the high school basketball season was their toughest to date. The Bearettes got a game-winning field goal from junior standout Rhyne Howard – on an assist by Halle Hughes – with no time left on the clock for a 48-46 non-district victory over stubborn Stone Memorial at Jim Smiddy Arena on Friday night. After a turnover ... (click for more)